- Issuer ticker
-
CORT
- Reported as of
-
21 May 2026
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
26 May 2026, 17:36:30 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Joseph Douglas Lyon, as attorney-in-fact for James N. Wilson
Key filing fact
James N. Wilson filed Form 4 for CORCEPT THERAPEUTICS INC (CORT) on 26 May 2026.
Key facts
- This page summarizes James N. Wilson's Form 4 filing for CORCEPT THERAPEUTICS INC (CORT).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 26 May 2026, 17:36.
Change
- Previous filing in this sequence was filed on 24 Apr 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001236387
Primary reporting owner
WILSON JAMES N
- Relationship
-
Director
- Address
- C/O CORCEPT THERAPEUTICS INCORPORATED, 101 REDWOOD SHORES PARKWAY, REDWOOD CITY
- Signature
- /s/ Joseph Douglas Lyon, as attorney-in-fact for James N. Wilson
- Signature date
- 26 May 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CORT
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +12,500
- Change %
- Price
-
$0.000000*
- Shares after
- 12,500
- Date
- 21 May 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,500
- Exercise price
- $59.69
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote
SEC remarks
The power of attorney under which this form was signed is on file with the Commission.